Cargando…

Familial Mediterranean Fever in childhood: a single center experience

Detalles Bibliográficos
Autores principales:	Barut, K, Sinoplu, AB, Yucel, G, Pamuk, G, Adrovic, A, Sahin, S, Kasapcopur, O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596962/ http://dx.doi.org/10.1186/1546-0096-13-S1-O12

Ejemplares similares

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
por: Barut, K, et al.
Publicado: (2015)

A case of systemic juvenile idiopathic arthritis with pulmonary hemosiderosis secondary to recurrent macrophage activation syndrome or a new autoinflammatory syndrome?
por: Barut, K, et al.
Publicado: (2015)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

Increased Frequency of Febrile Seizures in Two Periodic Fever Syndromes: Familial Mediterranean Fever and PFAPA Syndrome
por: Kılıç, Hüseyin, et al.
Publicado: (2022)

Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome: A Single-Center Experience
por: Yıldız, Mehmet, et al.
Publicado: (2022)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

PReS-FINAL-2304: Systemic lupus erythematosus in childhood: experience of single center (data of last ten years)
por: Kasapcopur, O, et al.
Publicado: (2013)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Screening of free carnitine and acyl-carnitine status in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Pulmonary hypertension in familial Mediterranean fever: consequence or coincidence?
por: Sargsyan, A, et al.
Publicado: (2015)

Evaluation of familial mediterranean fever patients: a single center experience
por: Gulez, P, et al.
Publicado: (2015)

Investigation of the inflammatory cell migration process in familial Mediterranean fever
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever
por: Rimar, D, et al.
Publicado: (2015)

Unified modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes
por: Gul, A, et al.
Publicado: (2015)

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
por: Ugurlu, S, et al.
Publicado: (2015)

Endothelial biomarkers in patients with familial Mediterranean fever associated vascular disease and vasculopathy
por: Sargsyan, Y, et al.
Publicado: (2015)

Autoinflammatory Diseases in Childhood
por: Yıldız, Mehmet, et al.
Publicado: (2020)

Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever
por: Yucel, Ilker Kemal, et al.
Publicado: (2011)

Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood
por: Onur, Hatice, et al.
Publicado: (2013)

Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF)
por: Latsoudis, H, et al.
Publicado: (2015)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
por: Haşlak, Fatih, et al.
Publicado: (2020)

Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
por: Haslak, Fatih, et al.
Publicado: (2020)

Musculoskeletal complaints in patients with Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents
por: Durcan, Gizem, et al.
Publicado: (2021)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Juvenile dermatomyositis: clinical features, laboratory findings, treatment modalities and disease course (a single center experience)
por: Kasapcopur, Ozgur, et al.
Publicado: (2014)

Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

The frequency of pulmonary hypertension in juvenile scleroderma
por: Adrovic, Amra, et al.
Publicado: (2014)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Single center experience with carotico-subclavian bypass
por: Kucuker, A, et al.
Publicado: (2013)

Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
por: Polat, Adem, et al.
Publicado: (2014)

A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C)
por: Haslak, Fatih, et al.
Publicado: (2021)

Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
por: ADROVIC, Amra, et al.
Publicado: (2020)

Juvenile spondyloartropathies
por: Yıldız, Mehmet, et al.
Publicado: (2022)

Coronary artery bypass grafting on the beating heart: 13-years experience in a single center
por: Bogáts, G, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2t1u7anf1sfmfd7v15jr3lmlc5